DigiM Image-Based PharmSci 2019 in Review

Read the Newsletter

Microstructures are essential in the development of pharmaceuticals. The size, distribution, and interplay of active pharmaceutical ingredients (API), excipients, and porosity are important to mechanistic understandings of drug performance. At DigiM, we have developed an integrated micro-imaging platform to take on challenges in formulation, product design, and process development. Our broad range of expertise includes the analysis of delicate pharmaceutical materials with micron and sub-micron resolution.   

Our platform includes high resolution correlative 3D imaging, AI-based image analysis, and image-based release prediction. We analyze a wide range of pharmaceutical samples including solid dosage forms, lyophilized biologics, and combination products, from early formulation development to final products in the market stage. See the sidebar for some of the unique challenges we have solved for our customers.

Our focus areas:
  • Q3 Microstructure Bioequivalence
  • Extended Release Characterization and Release Simulation
  • Solid Dosage Form Characterization
  • Lyophilized Biologics
Our analysis includes but is not limited to:
  • Microporosity
  • API Particle Size Distribution
  • Uniformity and Connectivity of API, Pore, and Excipient
  • Image Based Simulation of Physical Properties
    (including dissolution/release profile)
  • Geometry and Shape for Quality Control
  • Interface Characterization
    (including coatings)

Recent Presentations and Publications

  1. Zhang, S., Goldman, J., Chen, X., Rowe, J., Lin, S., Zhou, L. (2020). Non-Invasive, Quantitative Characterization of Lyophilized Drug Product Using Three-Dimensional X-Ray Microscopy Analytics. Drug Development & Delivery. Read full paper here.

  2. DigiM Awarded FDA Contract to Study Microstructure Bioquivalence. With UConn. Read the press release. News Medical press release available here.

  3. Zhou, L., Stroud, P., Zhu, A., Hinds, J., Blakely, K., Zhang, S. (2019). Characterization of Spray-Dried Aggregates for Tablet Formulation with Microstructure 3D Imaging Analytics. Poster presented at AAPS PharmSci 360 2019 in San Antonio, Texas. With Eli Lilly. Request poster.

  4. Zhou, L., Chen, X., Goldman, J., Rowe, J., Zhang, S., Lin, S. (2019). Non-invasive Three-dimensional X-Ray Microscopy Imaging Technique for Quantitative Characterization of Lyophilized Drug Product. Poster presented at AAPS PharmSci 360 2019 in San Antonio, Texas. With Bristol-Myers Squibb and Moderna. Request poster.

  5. Zhou, L., Lomeo J., & Zhang, S. (2019). Drug Substance / Drug Product Characterization and Performance Prediction Using High Resolution 3D Micro-Imaging Analysis. Poster presented at Applied Pharmaceutical Analysis 2019 Meeting in Boston, MA and recognized as an Outstanding Poster (September 9-11, 2019). Request a copy of the poster.

  6. Yost, E., Chalus, P., Zhang, S., Peter, S., & Narang, A. S. (2019). Quantitative X-Ray Microcomputed Tomography Assessment of Internal Tablet Defects. Journal of Pharmaceutical Sciences, 108(5), 1818-1830. With Genentech, Lonza, and Roche. Get official copy.